| Israel | Turki | Austria | |
| Pemeriksaan X-ray | dari $100 | dari $50 | dari $100 |
Bookimed tidak menambah biaya tambahan dalam harga Pemeriksaan X-ray. Tarif berasal dari daftar harga resmi klinik. Anda membayar langsung di klinik untuk Pemeriksaan X-ray Anda saat tiba.
Bookimed berkomitmen pada keselamatan Anda. Kami hanya bekerja dengan institusi medis yang menjaga standar internasional tinggi dalam Pemeriksaan X-ray dan memiliki izin yang dibutuhkan untuk melayani pasien internasional di seluruh dunia.
Bookimed menawarkan bantuan ahli gratis. Koordinator medis pribadi mendukung Anda sebelum, selama, dan setelah perawatan, menyelesaikan semua masalah Anda. Anda tidak pernah sendirian dalam perjalanan Pemeriksaan X-ray Anda.
Dr. Vladimir Goldman is a leading orthopedic surgeon in Israel. He heads the Limb Lengthening and Deformity Correction Department. Dr. Goldman is the only doctor in the country using the latest Stride magnetic nail technology. This method allows limb lengthening of up to 8 cm and lowers the risk of complications and infections.
He specializes in limb lengthening and deformity correction for children and adults. Dr. Goldman uses advanced internal and external fixation methods, including the Ilizarov technique. He has broad experience treating complex fractures, bone defects, and congenital conditions such as clubfoot and cerebral palsy.
Dr. Goldman graduated from the Hebrew University of Jerusalem. He completed advanced training at the Hospital for Special Surgery in New York. He has received recognition for his achievements. Dr. Goldman is a member of the Israeli Society of Pediatric Orthopedics and the North American Society for Limb Lengthening and Deformity Correction.
Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.
He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.